next-generation drug discovery: leveraging e3 ligases for targeted protein degradation
Published 4 years ago • 10K plays • Length 37:35Download video MP4
Download video MP3
Similar videos
-
24:20
leveraging the e3scantm technology platform for next-generation targeted protein degradation
-
45:51
paradigm shift in drug discovery: discover small molecule degraders using e3scan technology platform
-
17:46
recent trends in kinase drug discovery
-
1:05:17
unveiling the protac revolution: advancing drug discovery through targeted protein degradation
-
20:25
detection of protein turnover induced by targeted degraders
-
1:05:12
eurofins discovery services
-
39:11
biophysics in kinase drug discovery: fbs to protac® ternary complex characterisation
-
59:46
edrx webinar the value of gpcr cell based assays in drug discovery
-
2:02
eurofins discovery: it all starts with biology
-
55:18
eurofins integrated drug discovery webinar
-
4:49
biologics discovery and development - dr helge schnerr, fortébio
-
2:01
eurofins discovery: we know what it takes
-
0:36
hep-3b transfection kit
-
44:52
connecting the dots in early drug discovery at novartis
-
53:24
versatile hit-finding strategies for successful drug discovery programs
-
33:33
cellular target engagement as a new paradigm in drug discovery- elmar nurmemmedov, phd